These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 35336986)

  • 21. A Replicating Single-Cycle Adenovirus Vaccine Against Ebola Virus.
    Anguiano-Zarate SS; Matchett WE; Nehete PN; Sastry JK; Marzi A; Barry MA
    J Infect Dis; 2018 Nov; 218(12):1883-1889. PubMed ID: 29982595
    [TBL] [Abstract][Full Text] [Related]  

  • 22. EBOLA VACCINE. VSV-EBOV rapidly protects macaques against infection with the 2014/15 Ebola virus outbreak strain.
    Marzi A; Robertson SJ; Haddock E; Feldmann F; Hanley PW; Scott DP; Strong JE; Kobinger G; Best SM; Feldmann H
    Science; 2015 Aug; 349(6249):739-42. PubMed ID: 26249231
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of the inhibitory effect of an extract of Prunella vulgaris on Ebola virus glycoprotein (GP)-mediated virus entry and infection.
    Zhang X; Ao Z; Bello A; Ran X; Liu S; Wigle J; Kobinger G; Yao X
    Antiviral Res; 2016 Mar; 127():20-31. PubMed ID: 26778707
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of Vesicular Stomatitis Virus-Ebola Virus Postexposure Treatment in Rhesus Macaques Infected With Ebola Virus Makona.
    Marzi A; Hanley PW; Haddock E; Martellaro C; Kobinger G; Feldmann H
    J Infect Dis; 2016 Oct; 214(suppl 3):S360-S366. PubMed ID: 27496978
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Statins Suppress Ebola Virus Infectivity by Interfering with Glycoprotein Processing.
    Shrivastava-Ranjan P; Flint M; Bergeron É; McElroy AK; Chatterjee P; Albariño CG; Nichol ST; Spiropoulou CF
    mBio; 2018 May; 9(3):. PubMed ID: 29717011
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cholesterol-conjugated stapled peptides inhibit Ebola and Marburg viruses in vitro and in vivo.
    Pessi A; Bixler SL; Soloveva V; Radoshitzky S; Retterer C; Kenny T; Zamani R; Gomba G; Gharabeih D; Wells J; Wetzel KS; Warren TK; Donnelly G; Van Tongeren SA; Steffens J; Duplantier AJ; Kane CD; Vicat P; Couturier V; Kester KE; Shiver J; Carter K; Bavari S
    Antiviral Res; 2019 Nov; 171():104592. PubMed ID: 31473342
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ebolavirus Glycoprotein Fc Fusion Protein Protects Guinea Pigs against Lethal Challenge.
    Konduru K; Shurtleff AC; Bradfute SB; Nakamura S; Bavari S; Kaplan G
    PLoS One; 2016; 11(9):e0162446. PubMed ID: 27622456
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessing Antiviral Countermeasures Using Mouse Models of Ebolavirus Infection.
    Kroeker A; Griffin BD; Qiu X; Kobinger G
    Methods Mol Biol; 2017; 1628():273-282. PubMed ID: 28573628
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ebola virus - epidemiology, diagnosis, and control: threat to humans, lessons learnt, and preparedness plans - an update on its 40 year's journey.
    Singh RK; Dhama K; Malik YS; Ramakrishnan MA; Karthik K; Khandia R; Tiwari R; Munjal A; Saminathan M; Sachan S; Desingu PA; Kattoor JJ; Iqbal HM; Joshi SK
    Vet Q; 2017 Dec; 37(1):98-135. PubMed ID: 28317453
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Emergency Ebola response: a new approach to the rapid design and development of vaccines against emerging diseases.
    Tully CM; Lambe T; Gilbert SC; Hill AV
    Lancet Infect Dis; 2015 Mar; 15(3):356-9. PubMed ID: 25595637
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modelling Ebola virus dynamics: Implications for therapy.
    Martyushev A; Nakaoka S; Sato K; Noda T; Iwami S
    Antiviral Res; 2016 Nov; 135():62-73. PubMed ID: 27743917
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunization with vesicular stomatitis virus vaccine expressing the Ebola glycoprotein provides sustained long-term protection in rodents.
    Wong G; Audet J; Fernando L; Fausther-Bovendo H; Alimonti JB; Kobinger GP; Qiu X
    Vaccine; 2014 Sep; 32(43):5722-9. PubMed ID: 25173474
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Bivalent, Spherical Virus-Like Particle Vaccine Enhances Breadth of Immune Responses against Pathogenic Ebola Viruses in Rhesus Macaques.
    Singh K; Marasini B; Chen X; Ding L; Wang JJ; Xiao P; Villinger F; Spearman P
    J Virol; 2020 Apr; 94(9):. PubMed ID: 32075939
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of a cAdVax-based bivalent ebola virus vaccine that induces immune responses against both the Sudan and Zaire species of Ebola virus.
    Wang D; Raja NU; Trubey CM; Juompan LY; Luo M; Woraratanadharm J; Deitz SB; Yu H; Swain BM; Moore KM; Pratt WD; Hart MK; Dong JY
    J Virol; 2006 Mar; 80(6):2738-46. PubMed ID: 16501083
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An Adenovirus Vaccine Expressing Ebola Virus Variant Makona Glycoprotein Is Efficacious in Guinea Pigs and Nonhuman Primates.
    Wu S; Kroeker A; Wong G; He S; Hou L; Audet J; Wei H; Zhang Z; Fernando L; Soule G; Tran K; Bi S; Zhu T; Yu X; Chen W; Qiu X
    J Infect Dis; 2016 Oct; 214(suppl 3):S326-S332. PubMed ID: 27493239
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacologically induced endolysosomal cholesterol imbalance through clinically licensed drugs itraconazole and fluoxetine impairs Ebola virus infection
    Kummer S; Lander A; Goretzko J; Kirchoff N; Rescher U; Schloer S
    Emerg Microbes Infect; 2022 Dec; 11(1):195-207. PubMed ID: 34919035
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Polyphenylene carboxymethylene (PPCM) in vitro antiviral efficacy against Ebola virus in the context of a sexually transmitted infection.
    Escaffre O; Juelich TL; Freiberg AN
    Antiviral Res; 2019 Oct; 170():104567. PubMed ID: 31351092
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Ebola, the first vaccines available].
    Martin B; Volchkov V; Reynard O
    Med Sci (Paris); 2020 Nov; 36(11):1027-1033. PubMed ID: 33151849
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interferon-Induced HERC5 Inhibits Ebola Virus Particle Production and Is Antagonized by Ebola Glycoprotein.
    Paparisto E; Hunt NR; Labach DS; Coleman MD; Di Gravio EJ; Dodge MJ; Friesen NJ; Côté M; Müller A; Hoenen T; Barr SD
    Cells; 2021 Sep; 10(9):. PubMed ID: 34572049
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intranasal vaccination with ebola virus GP amino acids 258-601 protects mice against lethal challenge.
    Su QD; He SH; Yi Y; Qiu F; Lu XX; Jia ZY; Meng QL; Fan XT; Tian RG; Audet J; Qiu XG; Bi SL
    Vaccine; 2018 Oct; 36(41):6053-6060. PubMed ID: 30195490
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.